(Q34430163)

2 August 2017

title

N-methyl-D-aspartate antagonists for stroke and head trauma (English)

1 reference

2 August 2017

Wood PL

1

1 reference

2 August 2017

Hawkinson JE

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 April 1997

1 reference

Expert Opinion on Investigational Drugs

2 August 2017

published in

1 reference

2 August 2017

volume

6

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

389-397

1 reference

Amino acid neurotransmitters and their pathways in the mammalian central nervous system

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

Molecular Neurobiology of Glutamate Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

Lifetime cost of stroke in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

Introducing NMDA antagonists into clinical practice: why head injury trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

NMDA antagonist activity of (+/-)-(2SR,4RS)-4-(1H-tetrazol-5-ylmethyl)piperidine-2-carboxylic acid resides with the (-)-2R,4S-isomer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

Structural requirements for the development of potent N-methyl-D-aspartic acid (NMDA) receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

Focal cerebral ischemia in the cat: pretreatment with a competitive NMDA receptor antagonist, D-CPP-ene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

N-methyl-D-aspartate antagonist reduces stroke size and regional glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

Excitatory amino acid receptor antagonists: a novel treatment for ischemic cerebrovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

In vivo distribution of CGS-19755 within brain in a model of focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

The behavioral pharmacology of NMDA receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

Phencyclidine-induced psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

Neuronal vacuole formation in the rat posterior cingulate/retrosplenial cortex after treatment with the N-methyl-D-aspartate (NMDA) antagonist MK-801 (dizocilpine maleate).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

Pharmacological effects of the non-competitive NMDA antagonist CNS 1102 in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

Polyamine-sensitive binding of [125I]ifenprodil in washed, frozen-thawed synaptic membranes: evidence for high affinity binding requiring an open NMDA channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

Antagonist properties of the stereoisomers of ifenprodil at NR1A/NR2A and NR1A/NR2B subtypes of the NMDA receptor expressed in Xenopus oocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

Separation of .alpha.1-adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

(1S,2S)-1-(4-Hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: A Potent New Neuroprotectant Which Blocks N-Methyl-D-Aspartate Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

The glycine site of the NMDA receptor--five years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

Competitive antagonism of glycine at the N-methyl-d-aspartate (NMDA) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

A review of the in vitro and in vivo neurochemical characterization of the NMDA/PCP/glycine/ion channel receptor macrocomplex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

Glycine is a coagonist at the NMDA receptor/channel complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

The co-agonist concept: is the NMDA-associated glycine receptor saturated in vivo?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

1-Aminocyclopropane carboxylic acid: a potent and selective ligand for the glycine modulatory site of the N-methyl-D-aspartate receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

Pharmacological characteristics of cyclic homologues of glycine at the N-methyl-D-aspartate receptor-associated glycine site

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

Neuropharmacological characterization of 1-aminocyclopropane-1-carboxylate and 1-aminocyclobutane-1-carboxylate, ligands of the N-methyl-D-aspartate-associated glycine receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

A novel treatment of global cerebral ischaemia with a glycine partial agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

1-aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.4.389

21 January 2018

Identifiers

DOI

10.1517/13543784.6.4.389

1 reference

2 August 2017

1 reference